< Back to latest news & events

Event

IPBC Europe 2023

January 2023

HGF is a gold sponsor of IPBC Europe 2023 on the 27th – 29th of March in Paris.

The event will bring together elite decision-makers to discuss key policy, business, and legal developments, as well as the most effective strategies for maximising IP value in the increasingly dynamic European market.

HGF Partner & Head of Law Rachel Fetches will be moderating the panel “Avoiding UPC disasters”. This panel will cover:

    • How patentees and defendants can mitigate dangers
    • Rectifying the mistakes you may already have made
    • Strategies for parallel litigation in national courts

Attending the event are HGF Partners Craig Thomson, Dr Susan Keston & Harry Hutchinson.

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article